Search Results - "M. Weltman"

The brain--gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study by Koloski, N A, Jones, M, Kalantar, J, Weltman, M, Zaguirre, J, Talley, N J

“…Psychological factors are known to be associated with functional gastrointestinal disorders (FGIDs) including irritable bowel syndrome (IBS) and functional…”
Get more information

Systematic review with meta‐analysis: clinical manifestations and management of autoimmune hepatitis in the elderly by Chen, J., Eslick, G. D., Weltman, M.

“…Summary Background Autoimmune hepatitis is an uncommon chronic progressive inflammatory disease of the liver, characterised by hypergammaglobulianemia,…”
Get full text

Identification of early environmental risk factors for irritable bowel syndrome and dyspepsia by Koloski, N. A., Jones, M., Weltman, M., Kalantar, J., Bone, C., Gowryshankar, A., Walker, M. M., Talley, N. J.

“…Background The role of childhood environment including exposure to infection via siblings and pets in irritable bowel syndrome (IBS) and dyspepsia is…”
Get full text

Gastrointestinal: Pyoderma gangrenosum of the thumb by Sundaralingam, P, Weltman, M

Get full text

Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis by Weltman, Martin D., Farrell, Geoffrey C., Hall, Pauline, Ingelman‐Sundberg, Magnus, Liddle, Christopher

“…Nonalcoholic steatohepatitis (NASH) has multiple etiologic associations, but the pathogenesis is poorly understood. Cytochrome P450 (CYP) 2E1 is induced in the…”
Get full text

Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation by Weltman, MD, Farrell, GC, Liddle, C

“…BACKGROUND & AIMS: Nonalcoholic steatohepatitis is morphologically identical to alcoholic hepatitis and has multiple etiologic associations and an unknown…”
Get full text

Psychological impact and risk factors associated with new onset fecal incontinence by Koloski, N.A, Jones, M, Kalantar, J, Weltman, M, Zaguirre, J, Talley, N.J

“…Abstract Objectives We aim to evaluate the psychological impact and risk factors associated with new onset FI over 12 years in adults over 18 years for the…”
Get full text

Implementing guidelines on the prevention of opportunistic infections in inflammatory bowel disease by Walsh, A.J., Weltman, M., Burger, D., Vivekanandarajah, S., Connor, S., Howlett, M., Radford-Smith, G., Selby, W., Veillard, A.S., Grimm, M.C., Travis, S.P.L., Lawrance, I.C.

“…Opportunistic infections are a key safety concern in the management of patients with inflammatory bowel disease (IBD). Despite the existence of international…”
Get full text

IFNL3/4 genotype is associated with altered immune cell populations in peripheral blood in chronic hepatitis C infection by O'Connor, K S, Read, S A, Wang, M, Schibeci, S, Eslam, M, Ong, A, Weltman, M D, Douglas, M W, Mazzola, A, Craxì, A, Petta, S, Stewart, G J, Liddle, C, George, J, Ahlenstiel, G, Booth, D R

“…Single-nucleotide polymorphisms near the interferon lambda 3 ( IFNL3 ) gene predict outcomes to infection and anti-viral treatment in hepatitis C virus (HCV)…”
Get full text

Eradicating hepatitis C virus ameliorates insulin resistance without change in adipose depots by Milner, K-L., Jenkins, A. B., Trenell, M., Tid-Ang, J., Samocha-Bonet, D., Weltman, M., Xu, A., George, J., Chisholm, D. J.

“…Summary Chronic hepatitis C (CHC) is associated with lipid‐related changes and insulin resistance; the latter predicts response to antiviral therapy, liver…”
Get full text

Efficacy and safety of sofosbuvir/velpatasvir in people with chronic hepatitis C virus infection and recent injecting drug use: the SIMPLIFY study by Grebely, J, Dalgard, O, Conway, B, Cunningham, E, Bruggmann, P, Hajarizadeh, B, Amin, J, Marks, P, Quiene, S, Applegate, T.L, Swan, T, Byrne, J, Lacalamita, M, Dunlop, A.J, Bruneau, J, Hellard, M.E, Matthews, G.V, Powis, J, Shaw, D, Thurnheer, C.M, Weltman, M, Kronborg, I, Cooper, C, Feld, J.J, Fraser, C, Litwin, A, Dillon, J, Read, P, Gane, E, Dore, G.J

Get full text

P0848 : Efficacy of response-guided pegylated interferon and ribavirin therapy for people who inject drugs with HCV genotype 2/3 infection: The activate study by Grebely, J, Dalgard, O, Conway, B, Foster, G, Bruggmann, P, Backmund, M, Robaeys, G, Swan, T, Hajarizadeh, B, Amin, J, Marks, P, Quiene, S, Weltman, M, Shaw, D, Dunlop, A, Hellard, M, Bruneau, J, Bourgeois, S, Thurnheer, C, Dore, G.J

Get full text

901 VITAMIN D STATUS AND LIVER HISTOLOGY IN CHRONIC HEPATITIS C GENOTYPE 1 INFECTION: ANALYSIS OF THE AUSTRALASIAN CHARIOT STUDY COHORT by Kitson, M.T, Dore, G.J, Button, P, McCaughan, G, Crawford, D, Sievert, W, Weltman, M, Cheng, W, Roberts, S.K

Get full text

1126 VITAMIN D STATUS IS ASSOCIATED WITH COMPLETE EVR BUT NOT SVR IN CHRONIC HEPATITIS C GENOTYPE 1 INFECTION: ANALYSIS OF THE AUSTRALASIAN CHARIOT STUDY COHORT by Kitson, M.T, Dore, G.J, Button, P, McCaughan, G, Crawford, D, Sievert, W, Weltman, M, Cheng, W, Roberts, S.K

Get full text

CCR5-Δ32 genotype does not improve predictive value of IL28B polymorphisms for treatment response in chronic HCV infection by Suppiah, V, Armstrong, N J, O'Connor, K S, Berg, T, Weltman, M, Abate, M L, Spengler, U, Bassendine, M, Dore, G J, Irving, W L, Powell, E, Nattermann, J, Mueller, T, Riordan, S, Stewart, G J, George, J, Booth, D R, Ahlenstiel, G

“…IL28B polymorphisms strongly predict spontaneous and treatment-induced clearance of hepatitis C virus (HCV) infection. A recent study proposed a 32-base pair…”
Get full text

Chemical Analysis of Exhaled Vape Emissions: Unraveling the Complexities of Humectant Fragmentation in a Human Trial Study by Hopstock, Katherine S., Perraud, Véronique, Dalton, Avery B., Barletta, Barbara, Meinardi, Simone, Weltman, Robert M., Mirkhanian, Megan A., Rakosi, Krisztina J., Blake, Donald R., Edwards, Rufus D., Nizkorodov, Sergey A.

“…Electronic cigarette smoking (or vaping) is on the rise, presenting questions about the effects of secondhand exposure. The chemical composition of vape…”
Get full text

1192 HIGH SUSTAINED VIROLOGICAL RESPONSE RATES WITH RESPONSE-GUIDED DANOPREVIR PLUS PEGINTERFERON ALFA-2A (40KD) AND RIBAVIRIN IN TREATMENT-NAIVE, HCV GENOTYPE 1 PATIENTS: ATLAS STUDY FINAL RESULTS by Marcellin, P, Cooper, C, Balart, L.A, Larrey, D.G, Box, T.D, Yoshida, E, Lawitz, E, Buggisch, P, Ferenci, P, Weltman, M, Labriola-Tompkins, E, Le Pogam, S, Nájera, I, Thomas, D.N, Hooper, G, Shulman, N, Zhang, Y, Navarro, M.T, Lim, C.Y, Brunda, M, Yetzer, E.S, Terrault, N

Get full text

424 RESPIRATORY ALTERATIONS IN GENOTYPE 2/3 CHRONIC HEPATITIS C PATIENTS TREATED WITH PEGYLATED INTERFERON OR ALBINTERFERON-ALFA-2B PLUS RIBAVIRIN IN A RANDOMIZED STUDY by Foster, G, Flisiak, R, Chuang, W.-L, George, J, Rasenack, J, Sood, A, Komolmit, P, Thongsawat, S, Tanwandee, T, Sola, R, Sukeepaisarnjaroen, W, Weltman, M, Yin, Y, Feutren, G, Brown, K

Get full text

401 EARLY ON-TREATMENT PLASMA RIBAVIRIN CONCENTRATIONS ARE ASSOCIATED WITH ON-TREATMENT ANAEMIA AND TREATMENT OUTCOME IN CHRONIC HEPATITIS C GENOTYPE 1 PATIENTS by Ali, R.J, Roberts, S.K, Ray, J, Sievert, W, McCaughan, G, Weltman, M, Crawford, D, Cheng, W, Rawlinson, W, Thommes, J, Rizkalla, B, Yoshihara, M, Dore, G.J, Matthews, G.V

Get full text

Emissions Measurements from Household Solid Fuel Use in Haryana, India: Implications for Climate and Health Co-benefits by Weltman, Robert M, Edwards, Rufus D, Fleming, Lauren T, Yadav, Ankit, Weyant, Cheryl L, Rooney, Brigitte, Seinfeld, John H, Arora, Narendra K, Bond, Tami C, Nizkorodov, Sergey A, Smith, Kirk R

“…A large concern with estimates of climate and health co-benefits of “clean” cookstoves from controlled emissions testing is whether results represent what…”
Get full text